Los Angeles Capital Management’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
Other funds holding BVS
EWM
JIC
NCM
RA
Los Angeles Capital Management's BVS Position: Q2 2026 in Review
Los Angeles Capital Management increased its Bioventus (BVS) stake by 189,204% in Q2 2026, buying an estimated $1.26M and bringing the position to 132,513 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #690.
Los Angeles Capital Management first reported a position in BVS in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.71M in Q3 2024. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.
- Los Angeles Capital Management held 132,513 shares of Bioventus worth $1.25M as of Q2 2026.
- Los Angeles Capital Management bought 132,443 Bioventus shares in Q2 2026, an estimated $1.26M.
- Bioventus made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #690 holding.
- Los Angeles Capital Management first reported a position in Bioventus in Q4 2021 and has held it in 10 quarters since.
- Los Angeles Capital Management's Bioventus position peaked at $1.71M in Q3 2024.
- 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.
Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.